Goals: (1) To describe the prevalence of known risk factors for stroke morbidity and mortality in the Negev population that was hospitalized in the Soroka Hospital in the years 1995 and 1999, and to compare results. (2) To depict case fatality for those patients.

Methods: A cross-sectional study of two periods: 1995 and 1999. Data was collected from medical charts of patients admitted during the relevant time frame to Soroka Hospital in Beer Sheba, Israel with a primary diagnosis of stroke according to the ICD-9. Case fatality was defined as patient death within 30 days of admission.

Results: A total of 608 hospitalizations were included in the study of which 385 were admitted in 1995 and 222 in 1999. Most of the hospitalizations were due to ischemic stroke (86.7%), and the rest due to hemorrhagic stroke (13.3%). The average age was 71.1-10.9 years. Case fatality was 10.1% from ischemic stroke, 30.3% from hemorrhagic stroke and 12.5% from both. The case fatality was substantially higher in 1999. This trend was also observed in both ischemic and hemorrhagic stroke separately. There were no differences in demographic details between the years. Differences were found in various stroke risk factors. The first leukocyte count recorded was found to be significantly higher for patients who died of ischemic stroke in comparison to survivors. No differences were found between fatalities and survivors in the first reports of blood pressure.

Discussion: Patients in 1999 were found to have less risk factors and previously diagnosed diseases, and were admitted with more severe life threatening strokes. A logistic regression model, assessing the relationship between risk factors and case fatality, found that atrial fibrillation, type of stroke, admission leukocyte count, age and year contributed to the prediction of case fatality. Based on the results, it is recommended to use an admission leukocyte count above 11,000 to help identify patients at risk of death from stroke.

Download full-text PDF

Source

Publication Analysis

Top Keywords

case fatality
24
risk factors
16
stroke
12
ischemic stroke
12
hemorrhagic stroke
12
leukocyte count
12
morbidity mortality
8
negev population
8
years 1995
8
soroka hospital
8

Similar Publications

Cardiac tamponade is a rare but fatal complication of catheter ablation. We are reporting a case of a 73-year-old male with ventricular tachycardia (VT) storm undergoing urgent VT ablation, who was later found to have right ventricle (RV) perforation-an unusual site for catheter ablation complication. The patient underwent isochronal late activation mapping (ILAM)-based ablation and elimination of local abnormal ventricular activities (LAVA).

View Article and Find Full Text PDF

Introduction: Coronavirus disease 2019 (COVID-19) is a life-threatening disease that was declared a pandemic in March 2020. Organ transplant recipients are vulnerable to infection and complications from COVID-19. The objective of this study was to investigate the rates of infection, mortality, and case-fatality ratios (CFR) in solid organ transplant recipients and patients on the waiting list for organ allocation in the period prior to the availability of specific vaccines.

View Article and Find Full Text PDF

Acute Q Fever after Kidney Transplantation: A Case Report.

Br J Hosp Med (Lond)

January 2025

Department of Rheumatism and Immunity, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.

Patients receiving kidney transplant experience immunosuppression, which increases the risk of bacterial, viral, fungal, and parasitic infections. Q fever is a potentially fatal infectious disease that affects immunocompromised renal transplant recipients and has implications in terms of severe consequences for the donor's kidney. A patient with acute Q fever infection following kidney transplantation was admitted to the Tsinghua Changgung Hospital in Beijing, China, in March 2021.

View Article and Find Full Text PDF

Lassa fever (LF), a viral hemorrhagic fever disease with a case fatality rate that can be over 20% among hospitalized LF patients, is endemic to many West African countries. Currently, no vaccines or therapies are specifically licensed to prevent or treat LF, hence the significance of developing therapeutics against the mammarenavirus Lassa virus (LASV), the causative agent of LF. We used in silico docking approaches to investigate the binding affinities of 2015 existing drugs to LASV proteins known to play critical roles in the formation and activity of the virus ribonucleoprotein complex (vRNP) responsible for directing replication and transcription of the viral genome.

View Article and Find Full Text PDF

Nipah virus (NiV) is a zoonotic pathogen with the potential to cause human outbreaks with a high case fatality ratio. In this systematic review and meta-analysis, available evidence on NiV infections occurring in healthcare workers (HCWs) was collected and critically appraised. According to the PRISMA statement, four medical databases (PubMed, CINAHL, EMBASE, and Scopus) and the preprint repository medRixv were inquired through a specifically designed searching strategy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!